$DYN
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
Healthcare
Sector
Biotechnology
Industry
John G. Cox
CEO
192
Employees
$20.94
Current Price
$2.47B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 13 | $11,159,222.17 | 534,084 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 6 | 18 | $12,923,007.61 | 622,154 | ||
| 1 month | Buys | 1 | 2 | $77,580.00 | 4,500 | 1:166.58 |
| Sells | 6 | 18 | $12,923,007.61 | 622,154 | ||
| 2 months | Buys | 1 | 4 | $156,800.00 | 9,000 | 1:95.53 |
| Sells | 6 | 34 | $14,979,625.39 | 735,428 | ||
| 3 months | Buys | 1 | 4 | $156,800.00 | 9,000 | 1:331.03 |
| Sells | 6 | 78 | $51,904,917.49 | 2,635,156 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Lucera Erick Chief Financial Officer | Sale | 2,362 | $20.37 | $48,113.94 | View Details |
| Jun 23, 2026 | Rhodes Jason P Director | Sale | 39,131 | $21.13 | $826,838.03 | View Details |
| Jun 25, 2026 | Rhodes Jason P Director | Sale | 6,382 | $21.10 | $134,660.20 | View Details |
| Jun 24, 2026 | Rhodes Jason P Director | Sale | 25,397 | $21.02 | $533,844.94 | View Details |
| Jun 25, 2026 | Rhodes Jason P Director | Sale | 12,699 | $21.10 | $267,948.90 | View Details |
| Jun 23, 2026 | Rhodes Jason P Director | Sale | 77,855 | $21.13 | $1,645,076.15 | View Details |
| Jun 25, 2026 | Rhodes Jason P Director | Sale | 5,019 | $21.10 | $105,900.90 | View Details |
| Jun 24, 2026 | Rhodes Jason P Director | Sale | 50,530 | $21.02 | $1,062,140.60 | View Details |
| Jun 23, 2026 | Rhodes Jason P Director | Sale | 30,774 | $21.13 | $650,254.62 | View Details |
| Jun 24, 2026 | Rhodes Jason P Director | Sale | 19,973 | $21.02 | $419,832.46 | View Details |
| Jun 23, 2026 | Kersten Dirk Director | Sale | 71,629 | $21.04 | $1,506,766.16 | View Details |
| Jun 22, 2026 | Kersten Dirk Director | Sale | 190,676 | $20.57 | $3,922,262.52 | View Details |
| Jun 23, 2026 | Kersten Dirk Director | Sale | 1,657 | $21.47 | $35,582.75 | View Details |
| Jun 18, 2026 | Kersten Dirk Director | Sale | 46,901 | $20.07 | $941,373.42 | View Details |
| Jun 17, 2026 | Kersten Dirk Director | Sale | 37,454 | $20.14 | $754,316.07 | View Details |
| Jun 16, 2026 | Kerr Douglas Chief Medical Officer | Sale | 887 | $18.33 | $16,258.71 | View Details |
| Jun 16, 2026 | Friedl-Naderer Johanna Chief Commercial Officer | Sale | 145 | $18.33 | $2,657.85 | View Details |
| Jun 16, 2026 | Cox John Director | Sale | 2,683 | $18.33 | $49,179.39 | View Details |
| Jun 8, 2026 | Posner Brian S Director | Purchase | 2,000 | $16.94 | $33,880.00 | View Details |
| Jun 3, 2026 | Posner Brian S Director | Purchase | 2,500 | $17.48 | $43,700.00 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: